In a model of obesity-driven pancreatic cancer, Arg2 is upregulated in epithelial cells, and its knockdown reduces tumor growth in a cell autonomous manner, independently from immune responses (Zaytouni et al., 2017). The gene discussed is ARG2; the disease is neoplasm.